mRNA Therapeutics Market Size, Share & Trends Report

mRNA Therapeutics Market Size, Share & Trends Analysis Report By Application (Infectious Diseases, Oncology), By Type (Prophylactic Vaccines, Therapeutic Drugs), By End-use, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-957-3
  • Number of Pages: 110
  • Format: Electronic (PDF)

Market Segmentation

  • mRNA Therapeutics Application Outlook (Revenue, USD Million, 2020 - 2030)
    • Rare genetic diseases
    • Oncology
    • Respiratory diseases
    • Infectious diseases
    • Others
  • mRNA Therapeutics Type Outlook (Revenue, USD Million, 2020 - 2030)
    • Prophylactic vaccines
    • Therapeutic vaccines
    • Therapeutic drugs
  • mRNA Therapeutics End-use Outlook (Revenue, USD Million, 2020 - 2030)
    • Hospitals & clinics
    • Research organizations
    • Others
  • mRNA Therapeutics Regional Outlook (Revenue, USD Million, 2020 - 2030)
    • North America
      • North America mRNA Therapeutics Market, By Application
        • Rare genetic diseases
        • Oncology
        • Respiratory diseases
        • Infectious diseases
        • Others
      • North America mRNA Therapeutics Market, By Type
        • Prophylactic vaccines
        • Therapeutic vaccines
        • Therapeutic drugs
      • North America mRNA Therapeutics Market, By End-use
        • Hospitals & clinics
        • Research organizations
        • Others
      • U.S.
        • U.S. mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • U.S. mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • U.S. mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • Canada
        • Canada mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • Canada mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • Canada mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
    • Europe
      • Europe mRNA Therapeutics Market, By Application
        • Rare genetic diseases
        • Oncology
        • Respiratory diseases
        • Infectious diseases
        • Others
      • Europe mRNA Therapeutics Market, By Type
        • Prophylactic vaccines
        • Therapeutic vaccines
        • Therapeutic drugs
      • Europe mRNA Therapeutics Market, By End-use
        • Hospitals & clinics
        • Research organizations
        • Others
      • U.K.
        • U.K. mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • U.K. mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • U.K. mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • Germany
        • Germany mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • Germany mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • Germany mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • France
        • France mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • France mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • France mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • Italy
        • Italy mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • Italy mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • Italy mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • Spain
        • Spain mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • Spain mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • Spain mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
    • Asia Pacific
      • Asia Pacific mRNA Therapeutics Market, By Application
        • Rare genetic diseases
        • Oncology
        • Respiratory diseases
        • Infectious diseases
        • Others
      • Asia Pacific mRNA Therapeutics Market, By Type
        • Prophylactic vaccines
        • Therapeutic vaccines
        • Therapeutic drugs
      • Asia Pacific mRNA Therapeutics Market, By End-use
        • Hospitals & clinics
        • Research organizations
        • Others
      • Japan
        • Japan mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • Japan mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • Japan mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • China
        • China mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • China mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • China mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • India
        • India mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • India mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • India mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • Australia
        • Australia mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • Australia mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • Australia mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • South Korea
        • South Korea mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • South Korea mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • South Korea mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
    • Latin America
      • Latin America mRNA Therapeutics Market, By Application
        • Rare genetic diseases
        • Oncology
        • Respiratory diseases
        • Infectious diseases
        • Others
      • Latin America mRNA Therapeutics Market, By Type
        • Prophylactic vaccines
        • Therapeutic vaccines
        • Therapeutic drugs
      • Latin America mRNA Therapeutics Market, By End-use
        • Hospitals & clinics
        • Research organizations
        • Others
      • Brazil
        • Brazil mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • Brazil mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • Brazil  mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • Mexico
        • Mexico mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • Mexico mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • Mexico mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
    • MEA
      • MEA mRNA Therapeutics Market, By Application
        • Rare genetic diseases
        • Oncology
        • Respiratory diseases
        • Infectious diseases
        • Others
      • MEA mRNA Therapeutics Market, By Type
        • Prophylactic vaccines
        • Therapeutic vaccines
        • Therapeutic drugs
      • MEA mRNA Therapeutics Market, By End-use
        • Hospitals & clinics
        • Research organizations
        • Others
      • South Africa
        • South Africa mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • South Africa mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • South Africa mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • Saudi Arabia
        • Saudi Arabia mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • Saudi Arabia mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • Saudi Arabia mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others
      • UAE
        • UAE mRNA Therapeutics Market, By Application
          • Rare genetic diseases
          • Oncology
          • Respiratory diseases
          • Infectious diseases
          • Others
        • UAE mRNA Therapeutics Market, By Type
          • Prophylactic vaccines
          • Therapeutic vaccines
          • Therapeutic drugs
        • UAE mRNA Therapeutics Market, By End-use
          • Hospitals & clinics
          • Research organizations
          • Others

mRNA Therapeutics Market Dynamics

Driver: Rising Prevalence of Cancer

The incidence of cancer is rising globally, surpassing cardiovascular disease as the second greatest cause of death. This can be attributed to environmental reasons, including cigarette use, urbanization, growing pollution, changing dietary habits, and more affluence brought on by improved healthcare & an increase in postreproductive life duration. In addition, age-related risk accumulation for particular cancers is most likely the cause of the sharp rise in cancer incidence. Moreover, lung, breast, colon & rectum, stomach, liver, and hepatitis C are among the main cancers that cause death. Hence, growing sedentary life, increasing geriatric population, and others are a few factors improving the demand for mRNA Cancer therapeutics, propelling market growth over the forecast period. Furthermore, the consumption of alcohol and tobacco is surging across the globe.

According to WHO, tobacco use, a high body mass index, alcohol usage, a low intake of fruits & vegetables, and a lack of physical activity account for about one-third of cancer-related fatalities. Consequently, there is a greater need for mRNA cancer treatments. In addition, the lack of precision cancer therapy medications is pressuring the government and several leading players to invest extensively in R&D. Hence, the demand for mRNA cancer treatments is rising, driving market growth over the forecast period.

Driver: Academic and Industrial Interest in mRNA

 Recently, RNA centers have been established at numerous institutions to promote therapeutic uses for RNA, particularly in Vitro Transcribed (IVT) mRNA. These facilities include the Yale Center for RNA Science & Medicine, the RNA Institute at the University at Albany, the State University of New York, and the RNA Therapeutic Institute at the University of Massachusetts in the U.S.

In addition, university spin-off businesses funded by significant venture capital infusions (such as Argos Medicines, Factor Bioscience, CureVac, Ethris, BioNTech, Moderna, eTheRNA, and Onkaido) have advanced the preclinical and clinical development of mRNA-based therapeutics. Moreover, the testing of mRNA treatment is being done to encourage the development of new blood vessels. For instance, Moderna and AstraZeneca are working together on a myocardial ischemia therapy using mRNA (a form of cardiac disease that develops when there is a decrease in blood flow to the heart, depriving the heart muscle of necessary oxygen). Similarly, mRNA treatments for heart disease are being tested by Arcturus Therapeutics. Hence, several major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire.

Restraint: Stringent Government Regulations for mRNA-Based Product Approvals

 The regulatory framework for approval processes has always been the most critical restraining factor in the pharmaceutical, biotechnology, and medical technology industries. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries, such as China and India, where the mRNA therapeutics market holds immense growth potential due to a large patient base, is anticipated to impede market growth in the coming decade.

Such a discrete & uncertain scenario about the regulations for vaccines & therapeutics approval creates confusion among manufacturers regarding the commercialization of mRNA-based products. Moreover, in certain cases, POC for primary care practices are not properly resourced for reimbursements. The reimbursement structure varies in every region. For instance, different reimbursement structures exist across Europe with varied benefits and risks. This factor is expected to decrease the adoption of mRNA-based products among manufacturers.

What Does This Report Include?

This section will provide insights into the contents included in this mRNA therapeutics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

mRNA Therapeutics market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

mRNA Therapeutics market quantitative analysis

  • Market size, estimates, and forecast from 2020 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon